0.76
+0(+0.00%)
Currency In USD
| Previous Close | 0.76 |
| Open | 0.8 |
| Day High | 0.8 |
| Day Low | 0.76 |
| 52-Week High | 2.23 |
| 52-Week Low | 0.17 |
| Volume | 1,606 |
| Average Volume | 4,439 |
| Market Cap | 2.42M |
| PE | 0.99 |
| EPS | 0.77 |
| Moving Average 50 Days | 0.77 |
| Moving Average 200 Days | 0.52 |
| Change | 0 |
If you invested $1000 in Avenue Therapeutics, Inc. (ATXI) since IPO date, it would be worth $0.08 as of December 04, 2025 at a share price of $0.761. Whereas If you bought $1000 worth of Avenue Therapeutics, Inc. (ATXI) shares 5 years ago, it would be worth $0.2 as of December 04, 2025 at a share price of $0.761.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics
GlobeNewswire Inc.
Nov 06, 2025 12:00 PM GMT
Baergic shareholders eligible to receive up to approximately $82 million in potential development, regulatory, and sales milestones plus a tiered mid-to-high single digit royalty on global net sales from AxsomeMIAMI, Nov. 06, 2025 (GLOBE NEWSWIRE)
Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit
GlobeNewswire Inc.
Oct 09, 2024 12:30 PM GMT
MIAMI, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases